Cochrane Abstracts
Neoadjuvant chemotherapy versus none for resectable gastric cancer: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neoadjuvant Chemotherapy Versus None for Resectable Gastric Cancer: Cochrane Systematic Review." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer:_Cochrane_systematic_review. Accessed 06 October 2024.
Neoadjuvant chemotherapy versus none for resectable gastric cancer: Cochrane systematic review. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer:_Cochrane_systematic_review. Accessed October 6, 2024.
Neoadjuvant chemotherapy versus none for resectable gastric cancer: Cochrane systematic review. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer:_Cochrane_systematic_review
Neoadjuvant Chemotherapy Versus None for Resectable Gastric Cancer: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. [cited 2024 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neoadjuvant chemotherapy versus none for resectable gastric cancer: Cochrane systematic review
ID - 432013
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432013/all/Neoadjuvant_chemotherapy_versus_none_for_resectable_gastric_cancer:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -
